Restatement of Previously Issued Financial Statements (Tables)
|
9 Months Ended |
Sep. 30, 2021 |
|---|
| Condensed Financial Information Disclosure [Abstract] |
|
| Schedule of statement of operations |
| |
|
Three Months Ended September 30, 2021 |
|
| Statement of Operations for the Three Months Ended September 30,
2021 (unaudited) |
|
As
Previously
Reported |
|
|
Adjustments |
|
|
As Restated |
|
| Operating and formation costs |
|
$ |
417,261 |
|
|
$ |
(431 |
) |
|
$ |
416,830 |
|
| Warrant issuance costs |
|
$ |
(256,379 |
) |
|
$ |
101,342 |
|
|
$ |
(155,037 |
) |
| Change in fair value of warrant liabilities |
|
$ |
4,037,000 |
|
|
$ |
(7,656,500 |
) |
|
$ |
(3,619,500 |
) |
| Change in fair value of over-allotment option liability |
|
$ |
— |
|
|
$ |
(225,000 |
) |
|
$ |
(225,000 |
) |
| Net income (loss) |
|
$ |
3,341,073 |
|
|
$ |
(7,779,727 |
) |
|
$ |
(4,438,654 |
) |
| Basic net income (loss) per share of common stock |
|
$ |
0.19 |
|
|
$ |
(0.44 |
) |
|
$ |
(0.25 |
) |
| |
|
Nine Months Ended September 30, 2021 |
|
| Statement of Operations for the Nine Months Ended September 30, 2021 (unaudited) |
|
As Previously Reported |
|
|
Adjustments |
|
|
As Restated |
|
| Operating and formation costs |
|
$ |
417,261 |
|
|
$ |
(431 |
) |
|
$ |
416,830 |
|
| Warrant issuance costs |
|
$ |
(256,379 |
) |
|
$ |
101,342 |
|
|
$ |
(155,037 |
) |
| Change in fair value of warrant liabilities |
|
$ |
4,037,000 |
|
|
$ |
(7,656,500 |
) |
|
$ |
(3,619,500 |
) |
| Change in fair value of over-allotment option liability |
|
$ |
— |
|
|
$ |
(225,000 |
) |
|
$ |
(225,000 |
) |
| Net income (loss) |
|
$ |
3,341,073 |
|
|
$ |
(7,779,727 |
) |
|
$ |
(4,438,654 |
) |
| Basic net income (loss) per share of common stock |
|
$ |
0.34 |
|
|
$ |
(0.87 |
) |
|
$ |
(0.53 |
) |
|
| Schedule of statement of changes in stockholders’ equity (Deficit) |
| |
|
September 30, 2021 |
|
| |
|
As Previously Reported |
|
|
Adjustments |
|
|
As Revised |
|
| Statement of Changes in Stockholders’ Equity (Deficit) for the three and nine months ended
September 30, 2021 (unaudited) |
|
|
|
|
|
|
|
|
|
| Net proceeds from Initial Public Offering allocated to Rights, net of transaction costs |
|
$ |
— |
|
|
$ |
3,845,969 |
|
|
$ |
3,845,969 |
|
| Excess cash received over fair value of Private Placement Warrants |
|
$ |
1,076,250 |
|
|
$ |
3,085,250 |
|
|
$ |
4,161,500 |
|
| Change in fair value of over-allotment option liability |
|
$ |
— |
|
|
$ |
225,000 |
|
|
$ |
225,000 |
|
| Accretion of common stock to possible redemption amount |
|
$ |
(15,993,222 |
) |
|
$ |
623,508 |
|
|
$ |
(15,369,714 |
) |
| Net income (loss) |
|
$ |
3,341,073 |
|
|
$ |
(7,779,727 |
) |
|
$ |
(4,438,654 |
) |
|
| Schedule of statement of cash Flows |
| |
|
September 30, 2021 |
|
| |
|
As Previously Reported |
|
|
Adjustments |
|
|
As Revised |
|
| Statement of Cash Flows for the nine months ended September 30, 2021 (unaudited) |
|
|
|
|
|
|
|
|
|
| Net income (loss) |
|
$ |
3,341,073 |
|
|
$ |
(7,779,728 |
) |
|
$ |
(4,438,655 |
) |
| Warrant issuance costs |
|
$ |
256,379 |
|
|
$ |
(101,342 |
) |
|
$ |
155,037 |
|
| Change in fair value of warrant liabilities |
|
$ |
(4,037,000 |
) |
|
$ |
7,656,500 |
|
|
$ |
3,619,500 |
|
| Change in fair value of over-allotment option liability |
|
$ |
— |
|
|
$ |
225,000 |
|
|
$ |
225,000 |
|
| Accounts payable |
|
$ |
75,024 |
|
|
$ |
(431 |
) |
|
$ |
74,593 |
|
| Payment to related party for cancellation of Founder Shares |
|
$ |
— |
|
|
$ |
(16,667 |
) |
|
$ |
(16,667 |
) |
| Proceeds from sale of Founder Shares |
|
$ |
— |
|
|
$ |
16,667 |
|
|
$ |
16,667 |
|
|